Other Asanté™ Assays in Development

Sedia Biosciences is developing other rapid point-of-care assays on their Asanté™ platform.  The Asanté™ platform has the advantage of being suitable for a wide variety of specimen types, including blood, serum, plasma, oral fluid, urine and others.  The platform provides results in as little as 20 minutes and requires minimal training to perform.  Using a colloidal gold immunochromatography (lateral flow) design, the assays have excellent shelf lives and are robust in a wide range of environmental conditions.  

These assays may be available, but on a Research Use Only basis, unless otherwise indicated.


Assays in Development

  • Rapid HIV-1 Recency Assay for Estimation of HIV-Incidence - a rapid blood version of the Sedia™ HIV-1 LAg-Avidity EIA that differentiates recent from long-term HIV-1 infections and carries a confirmatory indicator to verify HIV-1 reactivity.  Used with blood, serum, plasma or dried blood spot specimens, the assay will be suitable for use in estimating HIV-1 incidence, population monitoring (similar to current applications for the Sedia™ HIV-1 LAg-Avidity EIA and the Sedia™ BED HIV-1 Incidence EIA) and for identifying recently infected individuals at elevated risk of disease transmission due to the high viral load typically present in early infections.   For additional information on this assay, click here.
  • Rapid Syphilis (Anti-Treponemal Antibody) Oral Fluid Test - an assay using the same oral fluid sampling mechanism employed by the Asanté™ HIV-1/2 Oral Fluid Rapid Test to collect oral fluid specimens, and test in a lateral flow format for the presence of anti-treponemal antibodies as an aid in the diagnosis of syphilis.
  • Rapid Hepatitis C (Anti-Hepatitis C Antibody) Blood/Oral Fluid Test - an assay also using the same oral fluid sampling mechanism employed by the Asanté™ HIV-1/2 Oral Fluid Rapid Test to collect oral fluid specimens, or suitable for use with blood, serum or plasma specimens.  The assay uses a lateral flow format to test for the presence of anti-Hepatitis C antibodies as an aid in the diagnosis of Hepatitis C.
  • Rapid HIV-1/2 (Anti-HIV-1/2 Antibody) Blood/Oral Combination Test - a combination blood or oral fluid version of the Asante™ HIV-1/2 Oral Fluid Test that can be used with whole blood (venous or fingerstick), serum, plasma or oral fluid.
  • Rapid Hepatitis B sAg (Hepatitis B Surface Antigen) Blood/Oral Fluid Test. - an assay also using the same oral fluid sampling mechanism employed by the Asanté™ HIV-1/2 Oral Fluid Rapid Test to collect oral fluid specimens, or suitable for use with blood, serum or plasma specimens.  The assay uses a lateral flow format to test for the presence of Hepatitis B surface antigen to establish an active acute or chronic infection of Hepatitis B. 
  • Rapid Anti-Hepatitis B Ab Blood/Oral Fluid Tests. - assays also using the same oral fluid sampling mechanism employed by the Asanté™ HIV-1/2 Oral Fluid Rapid Test to collect oral fluid specimens, or suitable for use with blood, serum or plasma specimens.  The assay uses a lateral flow format to test for the presence of anti-Hepatitis B core and surface antigen antibodies to establish previous or current exposure to Hepatitis B, or monitor effectiveness of Hepatitis B vaccination. 
  • Additional assays in development.  For more information, contact Sedia's Customer Service
| Home | About Us | Contact Us | Jobs | Privacy Policy | Terms of Use | Search | Site Map |     © Copyright 2016 - Sedia Biosciences Corporation
Top